ClinicalTrials.gg
CompletedNCT05843097SnapSBOUpdated Sep 19, 2024

SnapSBO - Small Bowel Obstruction Snapshot Audit

An observational study in Small Bowel Obstruction, sponsored by European Society for Trauma and Emergency Surgery. Completed at 1 site in Spain. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2024-09-19.

Primary conditionnone(registry's first term: Disease)No conditionIs this wrong?Disease describes something many studies share rather than a condition a study is about. The study names no condition we can place it under, so it is not compared with other studies by condition.

Sponsored by European Society for Trauma and Emergency Surgery · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,900
Ages
16 Years and older
Sex
All
01

Study summary

Small bowel obstruction (SBO) and its complications are frequently seen in patients admitted through the Emergency Departments of all acute care hospitals2.

There is variation in the optimal use of imaging, the appropriate timing and duration of non-operative management attempts, anti-microbial therapies, and the criteria for surgical management, which results in heterogeneity in approaches and outcomes across international clinical centers. The expected number of SBO cases in most clinical centers is predictable, enabling a suitably-sized cohort of patients to be gathered in the snapshot audit.

This 'ESTES snapshot audit' -a prospective observational cohort study- has a dual purpose. Firstly, as an epidemiological study, it aims to uncover the burden of disease. Secondly, it aims to demonstrate current strategies employed to diagnose and treat these patients. These twin aims will serve to provide a 'snapshot' of current practice, but will also be hypothesis-generating while providing a rich source of patient-level data to allow further analysis of the particular clinical questions.

Read the detailed description

Prospective audit of consecutive patients admitted in Emergency Department for mechanical small bowel obstruction over a 3-month period. The audit shall include unscheduled patient admissions from November 2023 until May 2024 as outlined in 'Key Study Dates'.

As this is an observational cohort audit, no change to normal patient management is required.

Primary Objective

To explore differences in patients, management and outcomes across the entire cohort to identify areas of practice variability resulting in apparent differences in outcome warranting further study. The outcomes that the study will examine are:

  • Incidence of small bowel obstruction by etiology.
  • Differences in clinical presentation.
  • Diagnostic work-up.
  • Non-operative management strategies.
  • Time to surgery and outcomes.
  • Complications related to disease and/or therapies within 60 post-operative days.
  • Length of Emergency Department and Hospital stay.
  • Re-admission within 6 months for related conditions.

Methods for identifying patients

Multiple methods may be used according to local circumstances/staffing:

  1. Daily review of emergency department (non-operative) and operating room lists.
  2. Daily review of team handover sheets / emergency admission lists / ward lists.
  3. Review of operating room logbooks.
  4. Use of electronic systems to flag any readmissions of patients identified and treated.
02

Conditions studied

  • Small Bowel Obstruction

Browse trials for

Keywords

  • diagnosis
  • management
  • guidelines
  • outcomes
03

In context

Lead sponsor

European Society for Trauma and Emergency Surgery is the lead sponsor of 5 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients (≥16 years of age) admitted for mechanical small bowel obstruction.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients (≥16 years of age) admitted for mechanical small bowel obstruction. Example etiologies which should be included:

    1. Adhesions.
    2. Hernias with bowel compromise (incisional/parastomal, ventral, inguinal, femoral, obturator, internal).
    3. (primary: lymphoma, carcinoid, GIST, adenocarcinoma/ disease: colon, ovarian, gastric, pancreatic, melanoma and others).
    4. Enteroliths/gallstones/bezoars/foreign bodies
    5. Radiation.
    6. Inflammation (Crohn's disease, mesenteric adenitis, appendicitis, diverticulitis, tuberculosis, actinomycosis, ascariasis).
    7. Congenital (malrotation, duplication cysts).
    8. Trauma (hematomas, ischemic strictures).

Exclusion criteria

Exclusion Criteria:

  • Functional small bowel obstruction (dysmotility or adynamic ileus secondary to abdominal operations, peritonitis, trauma or medications).
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

Metastases

Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,900 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Incidence of Small Bowel Obstruction, by etiology

    This study aims to quantify (as an integer, n) the etiologies of small bowel obstruction (adhesions, hernias, malignancy and other causes)

    Time frame: 6 months

  2. Time to Surgical Treatment of Small Bowel Obstruction vs Outcomes

    Time (hours) from hospital admission to Surgical Treatment of Small Bowel Obstruction vs Outcomes

    Time frame: 6 months

Secondary outcomes

  1. Complications related to operative or non-operative management of small bowel obstruction

    Complications related to operative or non-operative management of small bowel obstruction (integer count n,%) - for example haemorrhage, wound infection, venous thromboembolism, anastomotic leak

    Time frame: 6 months from hospital admission

  2. Adherence to evidence-based guidelines vs outcomes

    Adherence to evidence-based World Society of Emergency Surgery Bologna guideline 2020 recommendations (Table 5: available here https://wjes.biomedcentral.com/articles/10.1186/s13017-018-0185-2/tables/5) vs outcomes (30-day post operative or hospital discharge survival (median days), length of hospital stay (median days), Complications related to operative or non-operative management of small bowel obstruction (integer count n,%) - for example haemorrhage, wound infection, venous thromboembolism, anastomotic leak (integer count n,%)

    Time frame: 6 months from hospital admission

  3. Patient-related Outcome Metrics for Surgical vs Non-operative management

    Patient-related Outcome Metrics for Surgical vs Non-operative management, using the PROdiGI (Patient Reported Outcome Measure for GastroIntestinal Recovery) qualitative quality-of-life assessment tool specifically designed for gastro-intestinal symptoms in adult patients undergoing major abdominal surgery for indications OR patients being treated for intestinal obstruction regardless of etiology. Patients will be assisted in completing an anonymous survey where domains of gastrointestinal function are assessed using a 20-element Likert scales (with higher scores denoting worse perceived function) and a Visual Analog Scale 0-100 grading function from 0 (worst) to 100 (best).

    Time frame: At first post-discharge clinic visit, anticipated within 6 months of admission

07

Study locations

1 site
  • Hospital Universitario Virgen del Rocio
    Sevilla, Andalucia 41013, Spain
08

References and documents

Publications

  • Bass GA, Kaplan LJ, Ryan EJ, Cao Y, Lane-Fall M, Duffy CC, Vail EA, Mohseni S. The snapshot audit methodology: design, implementation and analysis of prospective observational cohort studies in surgery. Eur J Trauma Emerg Surg. 2023 Feb;49(1):5-15. doi: 10.1007/s00068-022-02045-3. Epub 2022 Jul 15. PubMed 35840703 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — The ESTES SnapAppy Group welcomes the use of these de-identified pooled data for further research that benefits patients. Requests can be submitted to the ESTES Research Committee. Release is subject to their approval and the appropriate safeguarding as determined by applicable legislation (GDPR and HIPAA).

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report

Time frame: After study main conclusions are published

Access criteria: Being one of study participating centers investigators

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Nov 2023 to primary completion in Sep 2024, 10 months.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 10, 2023
First posted
May 6, 2023
StartActual
Nov 1, 2023
Primary completionActual
Sep 1, 2024
CompletionActual
Sep 1, 2024
Last update
Sep 19, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05843097
Lead sponsor
European Society for Trauma and Emergency Surgery
Responsible party
Isidro Martinez Casas, MD PhD (Chair, SnapSBO Steering Group, European Society for Trauma and Emergency Surgery) — Principal investigator
First posted
May 6, 2023
Start date
Nov 1, 2023
Primary completion
Sep 1, 2024
Completion
Sep 1, 2024
Last update
Sep 19, 2024

Study contacts

Isidro Martínez Casas, MD PhD
principal investigator · Hospital Universitario Virgen del Rocio

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion